Literature DB >> 15162486

Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.

Christoph A Sotriffer1, Oliver Krämer, Gerhard Klebe.   

Abstract

Aldose reductase is a promising target for the treatment of diabetic complications, and as such, has become the focus of various drug design projects. As revealed by a survey of available crystal structures, the protein shows pronounced induced-fit effects upon ligand binding. Although helping to explain the enzyme's substrate promiscuity, phenomena of this kind are still responsible for significant complications in structure-based design efforts directed to aldose reductase. Accordingly, a deeper understanding of the principles governing conformational alterations in this enzyme would be of utmost practical importance. As a first step in addressing this issue, molecular dynamics (MD) simulations have been carried out. The ultrahigh resolution crystal structure of aldose reductase complexed with inhibitor IDD594 served as ideal starting point for a set of different simulations of nanosecond time scale: the native complexed state with bound inhibitor, the uncomplexed state (after removal of the inhibitor) at standard temperature, and the uncomplexed state at elevated temperature. The reference simulation of the complex exhibits extraordinary stability of the overall fold, whereas two distinct conformational substates are found for the binding-site region. In contrast, already at standard temperature pronounced changes are observed in the binding region during the simulation of the uncomplexed state. Leu300, for example, closes the access to the pocket opened by IDD594. On the other hand, conformations around the catalytic site are highly conserved, with the His110-Tyr48-NADP+ orientation being stabilized by a water molecule. Detailed analysis of the trajectories allows to reveal a set of distinct conformational substates that may prove useful as alternative structural templates in virtual screening for new aldose reductase inhibitors. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162486     DOI: 10.1002/prot.20021

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  13 in total

1.  Specificity in molecular design: a physical framework for probing the determinants of binding specificity and promiscuity in a biological environment.

Authors:  Mala L Radhakrishnan; Bruce Tidor
Journal:  J Phys Chem B       Date:  2007-11-03       Impact factor: 2.991

2.  Optimal drug cocktail design: methods for targeting molecular ensembles and insights from theoretical model systems.

Authors:  Mala L Radhakrishnan; Bruce Tidor
Journal:  J Chem Inf Model       Date:  2008-05-27       Impact factor: 4.956

3.  Homologous ligands accommodated by discrete conformations of a buried cavity.

Authors:  Matthew Merski; Marcus Fischer; Trent E Balius; Oliv Eidam; Brian K Shoichet
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

4.  Pharmacophore modeling, molecular docking, and molecular dynamics simulation approaches for identifying new lead compounds for inhibiting aldose reductase 2.

Authors:  Sugunadevi Sakkiah; Sundarapandian Thangapandian; Keun Woo Lee
Journal:  J Mol Model       Date:  2012-01-18       Impact factor: 1.810

5.  Comparison of crystal structures of human type 3 3alpha-hydroxysteroid dehydrogenase reveals an "induced-fit" mechanism and a conserved basic motif involved in the binding of androgen.

Authors:  Jean-François Couture; Karine Pereira de Jésus-Tran; Anne-Marie Roy; Line Cantin; Pierre-Luc Côté; Pierre Legrand; Van Luu-The; Fernand Labrie; Rock Breton
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

6.  BP-Dock: a flexible docking scheme for exploring protein-ligand interactions based on unbound structures.

Authors:  Ashini Bolia; Z Nevin Gerek; S Banu Ozkan
Journal:  J Chem Inf Model       Date:  2014-03-04       Impact factor: 4.956

7.  Target flexibility: an emerging consideration in drug discovery and design.

Authors:  Pietro Cozzini; Glen E Kellogg; Francesca Spyrakis; Donald J Abraham; Gabriele Costantino; Andrew Emerson; Francesca Fanelli; Holger Gohlke; Leslie A Kuhn; Garrett M Morris; Modesto Orozco; Thelma A Pertinhez; Menico Rizzi; Christoph A Sotriffer
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

8.  Consistent improvement of cross-docking results using binding site ensembles generated with elastic network normal modes.

Authors:  Manuel Rueda; Giovanni Bottegoni; Ruben Abagyan
Journal:  J Chem Inf Model       Date:  2009-03       Impact factor: 4.956

9.  Structure of aldose reductase from Giardia lamblia.

Authors:  M Ferrell; J Abendroth; Y Zhang; B Sankaran; T E Edwards; B L Staker; W C Van Voorhis; L J Stewart; P J Myler
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-08-16

10.  PocketPicker: analysis of ligand binding-sites with shape descriptors.

Authors:  Martin Weisel; Ewgenij Proschak; Gisbert Schneider
Journal:  Chem Cent J       Date:  2007-03-13       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.